A new international study has found that using higher doses of semaglutide, a medication commonly prescribed for type 2 ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.

In Phase III MINT trial, Uplizna (inebilizumab) demonstrated significant short-term efficacy and a manageable safety profile ...

Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...